PAR 0.00% 29.5¢ paradigm biopharmaceuticals limited..

Ann: Change of Director's Interest Notice, page-26

  1. 1,246 Posts.
    lightbulb Created with Sketch. 873
    Yes I tend to agree. Virus is still in play and will be for a minimum of atleast 2 months.
    With an increase in tests the graphs will steeply ascend, driving fear like a nail right through any economic stimulus headlines.

    PAR still very much a speccy (though de-risked significantly) and I expect this label to be a punishing one in the short term. The current SP is below my accumulation zone so I may start some small buys - but $0.845 is my main target from a volume/price perspective. This is an 80% discount from ATH. Unsure if we'll get there ofcourse but the probability of further SP drops is significant enough for me to wait.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
29.5¢
Change
0.000(0.00%)
Mkt cap ! $103.1M
Open High Low Value Volume
30.0¢ 30.0¢ 29.5¢ $34.55K 115.6K

Buyers (Bids)

No. Vol. Price($)
5 40478 29.5¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 10000 1
View Market Depth
Last trade - 16.10pm 22/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.